Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charis Eng

Showing results (391-400 of 555) with videos related to

Pageof 56
Sort By:
American Journal of Medical Genetics. Part A|August 23, 2021
Toward better characterization of restricted and repetitive behaviors in individuals with germline heterozygous PTEN mutationsMirko Uljarević, Thomas W Frazier, Gaëlle Rached, et al.
Human Molecular Genetics|December 25, 2016
Germline compound heterozygous poly-glutamine deletion in USF3 may be involved in predisposition to heritable and sporadic epithelial thyroid carcinomaYing Ni, Spencer Seballos, Benjamin Fletcher, et al.
Genome Medicine|April 17, 2021
Human breast microbiome correlates with prognostic features and immunological signatures in breast cancerAlice Tzeng, Naseer Sangwan, Margaret Jia, et al.
Neurology. Genetics|October 13, 2025
Neurodevelopmental and Neurologic Manifestations of <i>PTEN</i> Hamartoma Tumor Syndrome: Management RecommendationsAndrew Dhawan, Darren Liu, Sarah Baitamouni, et al.
Journal of Neurodevelopmental Disorders|January 14, 2023
Longitudinal neurobehavioral profiles in children and young adults with PTEN hamartoma tumor syndrome and reliable methods for assessing neurobehavioral changeRobyn M Busch, Thomas W Frazier Ii, Claire Sonneborn, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Genetic and clinical investigation of pheochromocytoma: a 22-year experience, from Freiburg, Germany to international effortBirke Bausch, Carsten C Boedeker, Ansgar Berlis, et al.
Signal Transduction and Targeted Therapy|July 31, 2021
Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19Yuan Hou, Yadi Zhou, Michaela U Gack, et al.
American Journal of Human Genetics|January 4, 2011
A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probandsMin-Han Tan, Jessica Mester, Charissa Peterson, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2005
Variable expression of coxsackie-adenovirus receptor in thyroid tumors: implications for adenoviral gene therapyDerek K Marsee, Douangsone D Vadysirisack, Carl D Morrison, et al.
Investigative Ophthalmology & Visual Science|April 19, 2012
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism arrayArun D Singh, Mary E Aronow, Yang Sun, et al.
Pageof 56

Showing results (391-400 of 555) with videos related to

Sort By:
Pageof 56
American Journal of Medical Genetics. Part A|August 23, 2021
Toward better characterization of restricted and repetitive behaviors in individuals with germline heterozygous PTEN mutationsMirko Uljarević, Thomas W Frazier, Gaëlle Rached, et al.
Human Molecular Genetics|December 25, 2016
Germline compound heterozygous poly-glutamine deletion in USF3 may be involved in predisposition to heritable and sporadic epithelial thyroid carcinomaYing Ni, Spencer Seballos, Benjamin Fletcher, et al.
Genome Medicine|April 17, 2021
Human breast microbiome correlates with prognostic features and immunological signatures in breast cancerAlice Tzeng, Naseer Sangwan, Margaret Jia, et al.
Neurology. Genetics|October 13, 2025
Neurodevelopmental and Neurologic Manifestations of <i>PTEN</i> Hamartoma Tumor Syndrome: Management RecommendationsAndrew Dhawan, Darren Liu, Sarah Baitamouni, et al.
Journal of Neurodevelopmental Disorders|January 14, 2023
Longitudinal neurobehavioral profiles in children and young adults with PTEN hamartoma tumor syndrome and reliable methods for assessing neurobehavioral changeRobyn M Busch, Thomas W Frazier Ii, Claire Sonneborn, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Genetic and clinical investigation of pheochromocytoma: a 22-year experience, from Freiburg, Germany to international effortBirke Bausch, Carsten C Boedeker, Ansgar Berlis, et al.
Signal Transduction and Targeted Therapy|July 31, 2021
Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19Yuan Hou, Yadi Zhou, Michaela U Gack, et al.
American Journal of Human Genetics|January 4, 2011
A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probandsMin-Han Tan, Jessica Mester, Charissa Peterson, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2005
Variable expression of coxsackie-adenovirus receptor in thyroid tumors: implications for adenoviral gene therapyDerek K Marsee, Douangsone D Vadysirisack, Carl D Morrison, et al.
Investigative Ophthalmology & Visual Science|April 19, 2012
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism arrayArun D Singh, Mary E Aronow, Yang Sun, et al.
Pageof 56